Ductal carcinoma in situ (DCIS): pathological features, differential diagnosis, prognostic factors and specimen evaluation. (Q37740955)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20436505%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

review article

1 reference

title

Ductal carcinoma in situ (DCIS): pathological features, differential diagnosis, prognostic factors and specimen evaluation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20436505%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20436505%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1

Sarah E Pinder

1 reference

22 August 2017

publication date

1 May 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20436505%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20436505%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

23 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20436505%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

S8-13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20436505%20AND%20SRC:MED&resulttype=core&format=json

The effect of margins on the clinical management of ductal carcinoma in situ of the breast

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

Optimal management of ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

Histological margin assessment for breast ductal carcinoma in situ: precision and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

Cytological and architectural heterogeneity in ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

Impact of a national external quality assessment scheme for breast pathology in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

Identification of a basal-like subtype of breast ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

Microinvasive carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

Prognostic and predictive molecular markers in DCIS: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

Factors affecting successful breast conservation for ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

7 January 2021

Prognostic classification of breast ductal carcinoma-in-situ

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

7 January 2021

Allelic imbalance analysis of chromosome 16q shows that grade I and grade III invasive ductal breast cancers follow different genetic pathways

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

7 January 2021

Tumour grade does not change between primary and recurrent mammary carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

7 January 2021

Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

7 January 2021

Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: A comparative study with long follow-up

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

7 January 2021

Predicting Invasion in Mammographically Detected Microcalcification

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

7 January 2021

Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

7 January 2021

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Gro

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

7 January 2021

Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast--results from the Swedish randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

7 January 2021

Atypical hyperplastic lesions of the female breast. A long-term follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

7 January 2021

Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

7 January 2021

Oestrogen receptor expression in the normal and pre-cancerous breast

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

7 January 2021

Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.40

7 January 2021